Cargando…
The clinical implications of choroidal thickness combined with tear VEGFA in coronary artery disease
OBJECTIVE: The purpose of this study was to evaluate the effect of choroidal thickness and tear vascular endothelial growth factor A (VEGFA) as biomarkers of coronary artery disease (CAD). METHODS: This study was a retrospective observational case–control trial. A total of 637 patients who underwent...
Autores principales: | Zhou, Tingquan, Wan, Ting, Jin, Xian, Chen, Yu, Shen, Chengxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538601/ https://www.ncbi.nlm.nih.gov/pubmed/37756415 http://dx.doi.org/10.1097/MCA.0000000000001279 |
Ejemplares similares
-
Choroidal thickness and granulocyte colony-stimulating factor in tears improve the prediction model for coronary artery disease
por: Romero-Trevejo, José Lorenzo, et al.
Publicado: (2022) -
Choroidal thickness in patients with coronary artery disease
por: Ahmad, Meleha, et al.
Publicado: (2017) -
Clinical Implication of Coronary Tortuosity in Patients with Coronary Artery Disease
por: Li, Yang, et al.
Publicado: (2011) -
Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
por: Gharbiya, Magda, et al.
Publicado: (2023) -
EFEMP1 is a potential biomarker of choroid thickness change in myopia
por: Shi, Wen-Qing, et al.
Publicado: (2023)